References
- WHO . Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities. Interim guidance.(2021).http://www.who.int/publications/i/item/WHO-2019-nCoV-lab-testing-2021.1-eng
- WHO . Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim guidance. (2020).http://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays
- Schildgen V , DemuthS, LüsebrinkJ, SchildgenO. Limits and opportunities of SARS-CoV-2 antigen rapid tests: an experienced-based perspective. Pathogens, 10(1), 38 (2021).
- Demuth S , DamaschekS, SchildgenO, SchildgenV. Low sensitivity of SARS-CoV-2 rapid antigen self-tests under laboratory conditions. New Microbes New Infect., 43, 100916 (2021).
- Platten M , HoffmannD, GrosserRet al. SARS-CoV-2, CT-values, and infectivity-conclusions to be drawn from side observations. Viruses, 13(8), 1459 (2021).
- Osterman A , BaldaufHM, EletrebyMet al. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med. Microbiol. Immunol., 210(1), 65–72 (2021).
- Mak GC , ChengPK, LauSSet al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J. Clin. Virol., 129, 104500 (2020).
- Mak GC , LauSS, WongKKet al. Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus. J. Clin. Virol., 133, 104684 (2020).
- WHO . Weekly epidemiological update on COVID-19 - 21 September 2021. Edition 48. http://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---21-september-2021
- Public Health England . Research and analysis. Variants: distribution of case data, 24 September 2021. (2021).http://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-case-data-24-september-2021
- CDC . SARS-CoV-2 variant classifications and definitions.(2021).http://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html
- European Centre for Disease Prevention and Control . Threat assessment brief: implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern. (2021).http://www.ecdc.europa.eu/en/publications-data/threat-assessment-emergence-and-impact-sars-cov-2-delta-variant.
- Public Health England . Increased household transmission of COVID-19 cases associated with SARS-CoV-2 variant of concern B.1.617.2: a national case-control study. https://khub.net/documents/135939561/405676950/Increased+Household+Transmission+of+COVID-19+Cases+-+national+case+study.pdf/7f7764fb-ecb0-da31-77b3-b1a8ef7be9aa
- Dougherty K , MannellM, NaqviO, MatsonD, StoneJ. SARS-CoV-2 B.1.617.2 (Delta) variant COVID-19 outbreak associated with a gymnastics facility - Oklahoma, April–May 2021. Morb. Mortal. Wkly Rep., 70(28), 1004–1007 (2021).
- Lam HY , LamTS, WongCHet al. The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong January to May 2020. Int. J. Infect. Dis., 98, 51–58 (2020).
- Centre for Health Protection . Latest situation of cases of COVID-19. http://www.chp.gov.hk/files/pdf/local_situation_covid19_en.pdf
- Mak GCK , LauAWL, ChanAMY, ChanDYW, TsangDNC. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong. J. Clin. Virol., 130, 104550 (2020).
- Mak GCK , LauAWL, ChanAMY, LamETK, ChanRCW, TsangDNC. The surveillance of spike protein for patients with COVID-19 detected in Hong Kong in 2020. J. Med. Virol., 93(9), 5644–5647 (2021).
- Tsang AKL , MakGCK, ChengPKCet al. Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong. J. Clin. Virol. Plus, 1(3), 100029 (2021).
- Tsang AKL , MakGCK, LeungPKLet al. Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong. J. Med. Virol., 94(1), 29–31 (2022).
- Brown KA , GubbayJ, HopkinsJet al. S-gene target failure as a marker of variant B.1.1.7 among SARS-CoV-2 isolates in the greater Toronto area, December 2020 to March 2021. JAMA, 325(20), 2115–2116 (2021).
- Bekliz M , AdeaK, Essaidi-LaziosiMet al. SARS-CoV-2 rapid diagnostic tests for emerging variants. Lancet Microbe, 2(8), e351 (2021).
- Jungnick S , HobmaierB, MautnerLet al. Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021. Euro. Surveill., 26(16), 2100413 (2021).
- WHO . WHO reference laboratories providing confirmatory testing for COVID-19. (2021).http://www.who.int/publications/m/item/who-reference-laboratories-providing-confirmatory-testing-for-covid-19
- Mak GCK , LauSSY, WongKKYet al. Evaluation of rapid antigen detection kit from the WHO Emergency Use list for detecting SARS-CoV-2. J. Clin. Virol., 134, 104712 (2020).
- Mak GCK , LauSSY, WongKKYet al. Evaluation of automated antigen detection test for detection of SARS-CoV-2. Diagn. Microbiol. Infect. Dis., 101(4), 115490 (2021).
- Mak GCK , LauSSY, WongKKYet al. Comparison of analytical sensitivity of the eight rapid antigen detection kits for detecting SARS-CoV-2 virus. J. Clin. Virol., 144, 104994 (2021).
- Zhou P , YangXL, WangXGet al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273 (2020).
- WHO . WHO Emergency Use listing for in vitro diagnostics (IVDs) detecting SARS-CoV-2. (2020).http://www.who.int/diagnostics_laboratory/201002_eul_sars_cov2_product_list.pdf?ua=1
- Stanford University . SARS-CoV-2 variants. (2021).https://covdb.stanford.edu/page/mutation-viewer
- Cheng PK , WongKK, MakGCet al. Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load. J. Clin. Virol., 47(2), 182–185 (2010).
- Vecchio CD , BrancaccioG, BrazzaleARet al. Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests. medRxiv doi: https://doi.org/10.1101/2021.03.25.21253802 (2021) ( Epub ahead of print).
- Bourassa L , PerchettiGA, PhungQet al. A SARS-CoV-2 nucleocapsid variant that affects antigen test performance. J. Clin. Virol., 141, 104900 (2021).
- Gandolfo C , MorecchiatoF, PistelloM, RossoliniGM, CusiMG. Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay. J. Clin. Virol., 142, 104942 (2021).
- Mak GCK , NgAYY, LamETK, ChanRCW, TsangDNC. Assessment of SARS-CoV-2 viral loads in combined nasal-and-throat swabs collected from COVID-19 individuals under the Universal Community Testing Programme in Hong Kong. J. Virol. Methods, 300, 114396 (2022).
- Lee J , SongJU, ShimSR. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: a systematic review and meta-analysis. J. Clin. Virol., 144, 104985 (2021).